Acquisition by Soffer Rock of 106383 shares of Longeveron LLC at 2.35 subject to Rule 16b-3
| LGVN Stock | USD 1.65 0.13 7.30% |
About 51% of Longeveron LLC's investor base is interested to short. The analysis of the overall investor sentiment regarding Longeveron LLC suggests that many traders are impartial. Longeveron LLC's investing sentiment overview a quick insight into current market opportunities from investing in Longeveron LLC. Many technical investors use Longeveron LLC stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Longeveron |
Filed transaction by Longeveron LLC Director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Longeveron LLC's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Longeveron LLC's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Longeveron LLC Fundamental Analysis
We analyze Longeveron LLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Longeveron LLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Longeveron LLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Longeveron LLC is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Longeveron LLC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Longeveron LLC stock to make a market-neutral strategy. Peer analysis of Longeveron LLC could also be used in its relative valuation, which is a method of valuing Longeveron LLC by comparing valuation metrics with similar companies.
Peers
Longeveron LLC Related Equities
| VRAX | Virax Biolabs | 39.41 | ||||
| FBRX | Forte Biosciences | 3.69 | ||||
| SRZN | Surrozen | 2.10 | ||||
| ERAS | Erasca | 0.38 | ||||
| EWTX | Edgewise Therapeutics | 0.53 | ||||
| KRON | Kronos Bio | 1.04 | ||||
| REVB | Revelation Biosciences | 2.86 | ||||
| KZR | Kezar Life | 3.53 | ||||
| KTTA | Pasithea Therapeutics | 4.51 | ||||
| INDP | Indaptus Therapeutics | 5.21 | ||||
| ABVC | ABVC Biopharma | 5.88 | ||||
| GBIO | Generation Bio | 6.42 | ||||
| KPRX | Kiora Pharmaceuticals | 6.59 | ||||
| QNRX | Quoin Pharmaceuticals | 6.67 | ||||
| NTRB | Nutriband | 7.25 | ||||
| KROS | Keros Therapeutics | 7.31 | ||||
| BOLT | Bolt Biotherapeutics | 7.41 | ||||
| CCCC | C4 Therapeutics | 9.63 | ||||
| LRMR | Larimar Therapeutics | 10.56 | ||||
| RNXT | RenovoRx | 11.20 |
Check out Longeveron LLC Hype Analysis, Longeveron LLC Correlation and Longeveron LLC Performance. To learn how to invest in Longeveron Stock, please use our How to Invest in Longeveron LLC guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Longeveron LLC. If investors know Longeveron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Longeveron LLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.62) | Revenue Per Share 0.364 | Quarterly Revenue Growth 1.157 | Return On Assets (0.62) | Return On Equity (1.42) |
The market value of Longeveron LLC is measured differently than its book value, which is the value of Longeveron that is recorded on the company's balance sheet. Investors also form their own opinion of Longeveron LLC's value that differs from its market value or its book value, called intrinsic value, which is Longeveron LLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Longeveron LLC's market value can be influenced by many factors that don't directly affect Longeveron LLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Longeveron LLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Longeveron LLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Longeveron LLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.